Literature DB >> 31142660

Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies.

Andrea Pilotto1,2, Alberto Romagnolo3, Jasmine A Tuazon4,5, Joaquin A Vizcarra4, Luca Marsili4, Maurizio Zibetti3, Michela Rosso6, Federico Rodriguez-Porcel4,7, Barbara Borroni1, Maria Cristina Rizzetti2, Carlo Rossi8, Darwin Vizcarra-Escobar9, Jennifer R Molano10, Leonardo Lopiano3, Roberto Ceravolo11, Mario Masellis12, Alberto J Espay4, Alessandro Padovani1, Aristide Merola13.   

Abstract

OBJECTIVE: Review the effect of orthostatic hypotension (OH) and rapid-eye-movement sleep behavioural disorder (RBD) on survival, cognitive impairment and postural stability, and discuss pathogenic mechanisms involved in the association of these two common non-motor features with relevant clinical outcomes in α-synucleinopathies.
METHODS: We searched PubMed (January 2007-February 2019) for human studies of OH and RBD evaluating cognitive impairment, postural instability, and survival in Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) and pure autonomic failure (PAF). Included studies were analysed for design, key results and limitations as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
RESULTS: OH and RBD showed a positive association with cognitive impairment in PD and DLB, conflicting association in PAF, and no association in MSA. OH was correlated with incident falls and postural instability in PD and DLB but not in MSA. The association between RBD and postural instability was inconclusive; positive in five studies, negative in seven. OH, but not RBD, correlated with reduced survival in PD, DLB and MSA. The combination of OH and RBD was associated with cognitive impairment and more rapid progression of postural instability.
CONCLUSIONS: OH and RBD yielded individual and combined negative effects on disability in α-synucleinopathies, reflecting a 'malignant' phenotype of PD with early cognitive impairment and postural instability. Underlying mechanisms may include involvement of selected brainstem cholinergic and noradrenergic nuclei. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Parkinson’s disease; autonomic; cognition; sleep disorders

Year:  2019        PMID: 31142660     DOI: 10.1136/jnnp-2019-320846

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Independent effect of neurogenic orthostatic hypotension on mild cognitive impairment in Parkinson's disease.

Authors:  Sung Hoon Kang; Su Jin Chung; Jungyeun Lee; Seong-Beom Koh
Journal:  Clin Auton Res       Date:  2021-11-29       Impact factor: 4.435

2.  Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease.

Authors:  Claudia Ledda; Elisa Montanaro; Leonardo Lopiano; Alberto Romagnolo; Gabriele Imbalzano; Aristide Merola; Ilaria Bruno; Carlo Alberto Artusi; Maurizio Zibetti; Mario Giorgio Rizzone; Marco Bozzali; Gabriele Sobrero; Fabrizio Vallelonga; Simona Maule
Journal:  Clin Auton Res       Date:  2022-08-28       Impact factor: 5.625

3.  Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson's Disease.

Authors:  Jiangnan Ma; Kaixin Dou; Ruize Liu; Yajin Liao; Zengqiang Yuan; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

4.  Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease.

Authors:  Katherine Longardner; Aristide Merola; Irene Litvan; Alberto Maria De Stefano; Simona Maule; Fabrizio Vallelonga; Leonardo Lopiano; Alberto Romagnolo
Journal:  J Neurol       Date:  2022-06-16       Impact factor: 6.682

5.  The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.

Authors:  Jose-Alberto Palma; Gabriel Redel-Traub; Angelo Porciuncula; Daniela Samaniego-Toro; Patricio Millar Vernetti; Yvonne W Lui; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2020-05-18       Impact factor: 4.891

6.  Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease.

Authors:  Don Gueu Park; Jae Whan Kim; Young-Sil An; Jaerak Chang; Jung Han Yoon
Journal:  J Neural Transm (Vienna)       Date:  2021-09-27       Impact factor: 3.575

7.  Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease.

Authors:  Alessandra Fanciulli; Nicole Campese; Georg Goebel; Jean Pierre Ndayisaba; Sabine Eschlboeck; Christine Kaindlstorfer; Cecilia Raccagni; Roberta Granata; Ubaldo Bonuccelli; Roberto Ceravolo; Klaus Seppi; Werner Poewe; Gregor K Wenning
Journal:  Neurology       Date:  2020-09-16       Impact factor: 9.910

8.  Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotension.

Authors:  Andrea Sturchio; Alok K Dwivedi; Luca Marsili; Aaron Hadley; Gabriele Sobrero; Dustin Heldman; Simona Maule; Leonardo Lopiano; Cristoforo Comi; Maurizio Versino; Alberto J Espay; Aristide Merola
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

Review 9.  The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Authors:  Per Borghammer
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders.

Authors:  Andrea Pilotto; Alberto Romagnolo; Andrea Scalvini; Mario Masellis; Yasushi Shimo; Laura Bonanni; Richard Camicioli; Lily L Wang; Alok K Dwivedi; Katherine Longardner; Federico Rodriguez-Porcel; Mark DiFrancesco; Joaquin A Vizcarra; Elisa Montanaro; Simona Maule; Alessandro Lupini; Carmen Ojeda-López; Sandra E Black; Stefano Delli Pizzi; Myrlene Gee; Ryota Tanaka; Kazuo Yamashiro; Taku Hatano; Barbara Borroni; Roberto Gasparotti; Maria C Rizzetti; Nobutaka Hattori; Leonardo Lopiano; Irene Litvan; Alberto J Espay; Alessandro Padovani; Aristide Merola
Journal:  Neurology       Date:  2021-06-07       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.